Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,791 | 745 | 99.9% |
| Education | $5.90 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $1,425 | 173 | $0 (2020) |
| ABBVIE INC. | $1,043 | 87 | $0 (2024) |
| PFIZER INC. | $1,009 | 76 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $814.64 | 50 | $0 (2024) |
| Novo Nordisk Inc | $696.94 | 52 | $0 (2024) |
| Lilly USA, LLC | $578.84 | 34 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $464.38 | 34 | $0 (2023) |
| GlaxoSmithKline, LLC. | $454.49 | 30 | $0 (2024) |
| Amarin Pharma Inc. | $347.86 | 22 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $321.06 | 19 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,111 | 71 | PFIZER INC. ($205.13) |
| 2023 | $1,196 | 88 | PFIZER INC. ($219.57) |
| 2022 | $1,522 | 106 | ABBVIE INC. ($279.20) |
| 2021 | $1,238 | 86 | AbbVie Inc. ($390.15) |
| 2020 | $1,135 | 95 | Allergan, Inc. ($316.48) |
| 2019 | $1,169 | 102 | Allergan Inc. ($348.14) |
| 2018 | $1,322 | 116 | Allergan Inc. ($427.78) |
| 2017 | $1,104 | 82 | Allergan Inc. ($332.24) |
All Payment Transactions
746 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $17.06 | General |
| Category: Medical Device | ||||||
| 12/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.27 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.15 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: PAIN | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Biological | ||||||
| 10/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $5.49 | General |
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.35 | General |
| 09/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: PAIN | ||||||
| 09/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Rare Disease | ||||||
| 07/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 160 | 251 | $66,100 | $19,786 |
| 2022 | 3 | 109 | 160 | $42,275 | $14,743 |
| 2020 | 16 | 364 | 658 | $80,935 | $49,283 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 178 | $48,950 | $14,097 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $7,250 | $3,093 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 44 | $9,900 | $2,597 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 110 | $30,250 | $10,110 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $7,750 | $3,339 | 43.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 19 | $4,275 | $1,294 | 30.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 39 | 178 | $22,250 | $14,724 | 66.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 39 | 55 | $12,650 | $8,847 | 69.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 34 | 113 | $9,718 | $6,393 | 65.8% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 33 | 64 | $8,192 | $3,724 | 45.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 31 | 31 | $7,750 | $3,496 | 45.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 34 | 44 | $4,444 | $2,540 | 57.1% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2020 | 18 | 23 | $3,703 | $2,312 | 62.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 13 | 13 | $2,756 | $1,908 | 69.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 37 | $3,219 | $1,736 | 53.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 13 | 13 | $1,586 | $1,096 | 69.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 14 | $1,792 | $967.63 | 54.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 13 | 13 | $1,313 | $746.51 | 56.9% |
| 90674 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 14 | 14 | $448.00 | $409.22 | 91.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 14 | 14 | $364.00 | $227.59 | 62.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 14 | 18 | $666.00 | $155.52 | 23.4% |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2020 | 11 | 14 | $84.00 | $0.20 | 0.2% |
About Dr. Stephen Matse, DO
Dr. Stephen Matse, DO is a Internal Medicine healthcare provider based in Johnstown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427054642.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Matse, DO has received a total of $9,797 in payments from pharmaceutical and medical device companies, with $1,111 received in 2024. These payments were reported across 746 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($9,791).
As a Medicare-enrolled provider, Matse has provided services to 633 Medicare beneficiaries, totaling 1,069 services with total Medicare billing of $83,812. Data is available for 3 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Johnstown, PA
- Active Since 06/22/2005
- Last Updated 05/24/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427054642
Products in Payments
- VRAYLAR (Drug) $690.25
- ELIQUIS (Drug) $582.09
- LINZESS (Drug) $568.09
- XIFAXAN (Drug) $536.49
- QULIPTA (Drug) $414.56
- FARXIGA (Drug) $364.50
- UBRELVY (Drug) $348.43
- Vascepa (Drug) $347.86
- NURTEC ODT (Drug) $341.76
- ENTRESTO (Drug) $306.07
- CHANTIX (Drug) $274.98
- XARELTO (Drug) $227.08
- MOUNJARO (Drug) $211.26
- SMARTVEST (Device) $173.66
- JARDIANCE (Drug) $157.56
- TRELEGY ELLIPTA (Drug) $154.45
- Aimovig (Biological) $147.25
- TRULICITY (Drug) $132.48
- APTIOM (Drug) $128.86
- ANORO (Drug) $128.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Johnstown
Charles Oschwald, Md, MD
Internal Medicine — Payments: $159,339
Leonardo Amper, Md, MD
Internal Medicine — Payments: $10,204
Dr. Shriram Sirsikar, M.d, M.D
Internal Medicine — Payments: $7,445
George Frem, Md, MD
Internal Medicine — Payments: $6,766
Dr. Balkissoon Maharajh, Md, MD
Internal Medicine — Payments: $6,020
Anwar Hussain, Md, MD
Internal Medicine — Payments: $4,458